KDR and neoplasm: The findings reported in these studies and our experience in the present study are in contrast to previous studies that characterized VEGFR2 expression using the same antibody (clone 55B11), in which little or no VEGFR2 expression was demonstrated in tumor cells from a variety of human tumor tissues analyzed [29], [50].